Johnson & Johnson

Stories 101 - 116 | << Prev 

Most Respected Companies

Apple heads the list, and Citigroup is dead last

(Newser) - Barron's has released its annual list on an admittedly squishy subject—how the world's largest 100 companies rank in terms of "respect." Two American firms showed up in the bottom 10: Bank of America at 93 and Citigroup dead last at 100. Here are the top 10...

Johnson & Johnson Charged Over Drug Kickbacks

Firm paid pharmacy tens of millions to push its drugs: feds

(Newser) - Federal prosecutors filed a complaint today against Johnson & Johnson, charging that it paid “tens of millions of dollars in kickbacks” to a major national pharmacy serving nursing homes. In exchange, the government alleges, that pharmacy, Omnicare Inc., would boost the sales of J&J’s drugs, including the...

Casey Johnson's Final Days Squalor-Filled

Details emerge of heiress' money troubles, house in shambles

(Newser) - As the initial autopsy results for Casey Johnson came back inconclusive but with no evidence of suicide, a slew of news—and opinions—about the heiress’s tragic final days also emerges. The latest:
  • Johnson was living in a house filled with garbage and rats in the pool, but with
...

Casey Johnson: Drama Surrounds Me
 Casey Johnson: 
 Drama Surrounds Me 
REMEMBRANCE
Jan 5, 2010 10:56 AM CST

Casey Johnson: Drama Surrounds Me

Heiress' troubled life remembered

(Newser) - Casey Johnson’s premature death caps a lifetime of trouble that the heiress herself summed up in a 2006 Vanity Fair piece: “Drama seems to kind of surround me.” Peter Davis, who first met Johnson a decade ago as a leather-clad “Chapin girl” who idolized Marilyn Monroe,...

Johnson & Johnson Heiress Found Dead

Cause of Casey's death unknown

(Newser) - The 30-year-old heir to the Johnson & Johnson empire has been found dead in her Los Angeles home. Casey Johnson's death appears to have been from natural causes, but the results of toxicology tests will take weeks, the Los Angeles Times reports. The hard-partying socialite, daughter of New York Jets...

Johnson & Johnson to Slash 8,700 Jobs

Company says moves will save up to $900M annually

(Newser) - Johnson & Johnson will cut 7% of its workforce—some 8,400 jobs—and make other other restructuring moves in order to save up to $900 million next year. The New Brunswick, NJ, company says it will also simplify its business structure in order to achieve savings that will add...

Dow Up 124 on Revitalized M&amp;A
 Dow Up 124 on Revitalized M&A 
MARKETS
Sep 28, 2009 3:18 PM CDT

Dow Up 124 on Revitalized M&A

Xerox, J&J announce new acquisitions

(Newser) - High-profile deals breathed fresh life into stocks today, snapping a 3-day losing streak. Xerox will buy outsourcing company Affiliated Computer Services for $6.4 billion, and Johnson and Johnson bought biotech firm Crucell for $442.7 million. Barring sharp losses in the days ahead, this quarter will have seen the...

Companies, to Their Lobbyist: Wait, We Care About Climate

Chamber of Commerce faces enviro dissent

(Newser) - Cracks are appearing in big business’s monolithic opposition to federal moves to prevent climate change. Politico reports that major members of the Chamber of Commerce, including Nike and Johnson & Johnson, are complaining about the Chamber's resistance to measures like the cap-and-trade bill in Congress. A Nike spokeswoman says...

FBI Searches Home of Tylenol Killings Suspect
FBI Searches
Home of Tylenol Killings Suspect
updated
Feb 4, 2009 3:37 PM CST

FBI Searches Home of Tylenol Killings Suspect

Case of seven deaths in 1982 poisoning remains unsolved

(Newser) - FBI agents are searching the former residence of a suspect in the deaths of seven people who took cyanide-laced Tylenol in 1982, the Boston Globe reports. The case has never been solved, and agents say they are reviewing all related evidence. James W. Lewis lived in the Boston-area apartment after...

Congress to Probe 'Misleading' Drug Ads

Cholesterol, anemia drugs in spotlight

(Newser) - A congressional panel will examine three ad campaigns as part of a move to tighten regulations on drug companies' direct-to-consumer marketing, the Wall Street Journal reports. The committee will focus on ads for cholesterol drugs Vytorin and Lipitor, and anemia drug Procrit, which has been promoted as an anti-fatigue drug...

J&J Hid Birth Control Patch Risks: Suit

Scientist accused of veiling heart attack, stroke dangers

(Newser) - Johnson & Johnson doctored data to get its birth control patch FDA-approved, according to a class action lawsuit that claims Ortho-Evra caused blood clots, heart attacks, and strokes. A J&J scientist allegedly doctored the data with a "correction factor" for the FDA, lowering estrogen-related risk by 60%: He...

Overdose Fears Prompt Recall of Infant Drugs

Danger found in cough and cold medicines for kids under 2

(Newser) - Several drugmakers have recalled over-the-counter cough and cold products for infants over concerns about fatal overdoses, Reuters reports. Johnson & Johnson Wyeth and Novartis are among those recalling medicines; CVS said it will remove the products and generic equivalents. One professor took the criticism one step further: “There are...

Credit Crunch Hits Bond Market
Credit Crunch Hits Bond Market
Aug 20, 2007 3:36 AM CDT

Credit Crunch Hits Bond Market

Tight corporate borrowing could slow economy

(Newser) - Ripples from the credit crisis have reached the corporate bond market—threatening to slow down the economy by seriously limiting the ability of major corporations to borrow money for new projects,  the Washington Post reports. Credit problems have already begun to bite into the future plans of Hertz, ...

Drug Giant Sues Red Cross Over ... Red Cross

Johnson & Johnson claims trademark infringement

(Newser) - Pharmaceutical behemoth Johnson & Johnson has filed a lawsuit in federal court against the American Red Cross over its signature logo, the Wall Street Journal reports. The suit claims the humanitarian organization is violating the Johnson & Johnson trademark by licensing the signature red cross symbol to companies for use...

Dow Breaks 14K, Briefly
Dow Breaks 14K, Briefly
Jul 17, 2007 3:56 PM CDT

Dow Breaks 14K, Briefly

Strong earnings, weak inflation boost markets

(Newser) - The Dow shattered the 14,000 mark for the first time in its history today, floating 22 points above the milestone but dipping just before the bell to close at 13,971.55—still a 20.57-point gain. A projection of relatively docile inflation, combined with continued encouraging earnings reports...

Doctors Paid Millions To Use Anemia Drugs

Among the world's top-selling medicines, the FDA now says they may be unsafe

(Newser) - Doctors are paid millions of dollars by drug companies to give their patients anemia medicine which regulators now say may be dangerous. Spurred by competiton between several similar drugs, companies reward doctors with rebates, which allow them to make a significant profit, the New York Times reports.

Stories 101 - 116 | << Prev